Cytotoxic effect caspase activation dependent of a genetically engineered fusion protein with a CD154 peptide mimetic (OmpC-CD154p) on B-NHL cell lines is mediated by the inhibition of bcl-6 and YY1 through MAPK p38 activation-Reference-Cited by-同舟云学术

Cytotoxic effect caspase activation dependent of a genetically engineered fusion protein with a CD154 peptide mimetic (OmpC-CD154p) on B-NHL cell lines is mediated by the inhibition of bcl-6 and YY1 through MAPK p38 activation

Published:2018-10-02 Issue:4 Volume:60 Page:1062-1070
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Pantoja-Escobar Gerardo¹²,Morales-Martínez Mario²,Vega Gabriel G.²,Castro-Escarpulli Graciela¹,Vega Mario I.²³^ORCID

Affiliation:

1. Departamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Laboratorio de Investigación Clínica y Ambiental, Mexico City, Mexico;

2. Molecular Signal Pathways in Cancer Laboratory, UIMEO, Oncology Hospital, Siglo XXI National Medical Center, IMSS, Mexico City, Mexico;

3. Department of Medicine, Hematology-Oncology Division VA West Los Angeles Medical Center BBRI UCLA Medical Center Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA

Funder

CONACyT

IMSS

Fondo de Investigacion en Salud IMSS

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2018.1516286

Reference29 articles.

1. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011